Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 1000)

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)	Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, angiomatosis, cancer, cardiovascular disorder, hereditary disease, neoplasm, nervous system disorder, neurocutaneous syndrome, vascular disorder, von Hippel-Lindau disease	Recruiting	Phase 3	2026-10-06		NCT07405164

Clinical trials